Showing results (101-110 of 256) with videos related to

Sort By:
Pageof 26
Biochemical and Biophysical Research Communications|November 2, 2025
Oral administration of Enterococcus faecalis to mice induces acute and chronic inflammation in the pancreas: possible involvement in the pathophysiology of pancreatic diseasesMunefumi Shimosaka, Yudai Ishida, Shinji Takamatsu, et al.
The Prostate|May 8, 2014
Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancerKazutoshi Fujita, Mayuka Shimomura, Motohide Uemura, et al.
Journal of Biochemistry|November 17, 2018
Core fucose is essential glycosylation for CD14-dependent Toll-like receptor 4 and Toll-like receptor 2 signalling in macrophagesKotarosumitomo Nakayama, Kana Wakamatsu, Hironobu Fujii, et al.
Oncology|May 31, 2008
Immunohistochemical study of glypican 3 in thyroid cancerKanako Yamanaka, Yasuhiro Ito, Noriko Okuyama, et al.
Clinical Chemistry and Laboratory Medicine|February 5, 2010
Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancerHitoshi Matsumoto, Shinichiro Shinzaki, Megumi Narisada, et al.
Frontiers in Oncology|May 11, 2023
Terminal fucosylation of haptoglobin in cancer-derived exosomes during cholangiocarcinoma progressionHyewon Choi, Sungeun Ju, Keunsoo Kang, et al.
World Journal of Gastroenterology|November 3, 2015
Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reactionMasahiro Tanemura, Eiji Miyoshi, Hiroaki Nagano, et al.
Glycoconjugate Journal|February 14, 2023
Twin research shows glycan changes are more susceptible to environmental factors than their carrier glycoproteinsTatsuya Asuka, Yoshihiro Kamada, Koichi Morishita, et al.
Cancer Science|March 12, 2011
Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicityKenta Moriwaki, Kumiko Okudo, Naotsugu Haraguchi, et al.
Pageof 26